Tibet Weixinkang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	300.54	216.44	269.43	519.32	243.77	219.52
Trading Asset Securities	717	803	625.32	287	467.78	356
Cash & Short-Term Investments	1,018	1,019	894.75	806.32	711.55	575.52
Cash Growth	-3.95%	13.94%	10.97%	13.32%	23.64%	8.67%
Accounts Receivable	158.98	172.29	179.77	222.85	193.13	229.07
Other Receivables	2.24	1.93	2.2	2.14	1.22	1.08
Receivables	161.22	174.22	181.96	224.99	194.35	230.15
Inventory	46.66	41.96	38.34	32.54	22.68	21.68
Prepaid Expenses	-	2.62	1.73	1.68	2.14	-
Other Current Assets	115.69	77.14	83.12	73.43	78.44	67.6
Total Current Assets	1,341	1,315	1,200	1,139	1,009	894.95
Property, Plant & Equipment	396.56	380.25	361.21	333.73	324.14	314.19
Long-Term Investments	84.44	69.05	75.88	71.33	62.49	58.77
Other Intangible Assets	22.49	16.59	35.39	24.4	12.83	17.98
Long-Term Deferred Tax Assets	31.13	42.92	56.21	30.18	9.75	12.46
Long-Term Deferred Charges	12.26	16.91	26.36	41.52	73.35	52.91
Other Long-Term Assets	21.42	12.59	21.93	25.29	3.85	8.8
Total Assets	1,909	1,854	1,777	1,665	1,496	1,360
Accounts Payable	224.69	5.48	1.47	3.5	0.85	9.26
Accrued Expenses	9.92	314.28	269.95	284.17	271.98	285.1
Current Portion of Leases	2.44	2.89	3.86	2.31	2.47	-
Current Income Taxes Payable	13.93	0.66	3.83	6.78	4.3	3.86
Current Unearned Revenue	4	7.24	4.4	6.54	7.75	8.98
Other Current Liabilities	74.64	96.63	111.27	108.5	131.92	61.65
Total Current Liabilities	329.62	427.18	394.79	411.8	419.26	368.85
Long-Term Leases	6.39	2.38	3.82	3.48	2.35	-
Long-Term Unearned Revenue	5.76	7.05	3.84	5.25	6.7	8
Long-Term Deferred Tax Liabilities	12.33	2.78	3.46	1.17	-	-
Other Long-Term Liabilities	28.86	28.86	30.64	23.14	-	-
Total Liabilities	382.95	468.24	436.55	444.84	428.31	376.85
Common Stock	435.16	435.16	435.16	435.16	435.92	423
Additional Paid-In Capital	347.64	347.64	347.15	341.35	318.64	256.83
Retained Earnings	772.64	631.28	579.63	453.82	346.51	289.61
Treasury Stock	-30	-30	-22.37	-23.8	-52.88	-
Comprehensive Income & Other	1.02	1.36	0.78	14.05	19.07	13.77
Total Common Equity	1,526	1,385	1,340	1,221	1,067	983.21
Shareholders' Equity	1,526	1,385	1,340	1,221	1,067	983.21
Total Liabilities & Equity	1,909	1,854	1,777	1,665	1,496	1,360
Total Debt	8.82	5.27	7.68	5.79	4.81	-
Net Cash (Debt)	1,009	1,014	887.07	800.53	706.73	575.52
Net Cash Growth	-3.76%	14.33%	10.81%	13.27%	22.80%	8.67%
Net Cash Per Share	2.35	2.35	2.07	1.85	1.69	1.38
Filing Date Shares Outstanding	432.33	432.33	435.16	435.16	435.92	423
Total Common Shares Outstanding	432.33	432.33	435.16	435.16	435.92	423
Working Capital	1,011	888.19	805.12	727.17	589.9	526.1
Book Value Per Share	3.53	3.20	3.08	2.80	2.45	2.32
Tangible Book Value	1,504	1,369	1,305	1,196	1,054	965.23
Tangible Book Value Per Share	3.48	3.17	3.00	2.75	2.42	2.28
Buildings	-	285.16	280.15	260.92	258.81	230.87
Machinery	-	297.15	274.57	236.19	215.29	196.97
Construction In Progress	-	37.98	15.19	17.11	-	19.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.